Recent Company News

• 10:15 AM ET Jun 11, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (64 total)

• 07:32 AM ET Jun 11, 2025
  

  BrainsWay reports results from multicenter randomized study of accelerated deep TMS for major depressive disorder (MDD) ($11.46, 0.00)

• 07:31 AM ET Jun 04, 2025
  

  Brainsway announces $5M minority-stake investment in Stella MSO, LLC ($10.19, 0.00)

• 07:37 AM ET May 13, 2025
  

  Brainsway reports Q1 EPS $0.02 vs FactSet $0.02 [4 est, $0.01-0.03] ($8.83, 0.00)

• 07:35 AM ET Mar 11, 2025
  

  Brainsway reports Q4 EPS $0.04 vs FactSet $0.02 [4 est, $0.02-0.03] ($9.19, 0.00)

• 10:11 AM ET Feb 18, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (193 total)

• 10:11 AM ET Feb 14, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (202 total)

• 08:06 AM ET Dec 12, 2024
  

  Brainsway reports positive independent pilot data on accelerated deep TMS treatment of alcohol use disorder ($9.81, 0.00)

• 08:03 AM ET Nov 20, 2024
  

  Brainsway reports promising feasibility data showing pain reduction with deep TMS Therapy ($9.67, 0.00)

• 09:21 AM ET Nov 12, 2024
  

  StreetAccount Summary - US Pre-market trading update